Y-mAbs Therapeutics Inc (YMAB)
17.15
-0.10
(-0.58%)
USD |
NASDAQ |
May 03, 16:00
17.11
-0.04
(-0.23%)
After-Hours: 20:00
Y-mAbs Therapeutics Net Income (Quarterly): -0.988M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.988M |
September 30, 2023 | -7.747M |
June 30, 2023 | -6.302M |
March 31, 2023 | -6.39M |
December 31, 2022 | 1.157M |
September 30, 2022 | -27.53M |
June 30, 2022 | -41.13M |
March 31, 2022 | -28.07M |
December 31, 2021 | -36.89M |
September 30, 2021 | -28.86M |
June 30, 2021 | -22.94M |
March 31, 2021 | 33.41M |
December 31, 2020 | -19.93M |
Date | Value |
---|---|
September 30, 2020 | -32.83M |
June 30, 2020 | -40.39M |
March 31, 2020 | -26.18M |
December 31, 2019 | -23.14M |
September 30, 2019 | -23.92M |
June 30, 2019 | -18.04M |
March 31, 2019 | -15.93M |
December 31, 2018 | -14.06M |
September 30, 2018 | -11.43M |
June 30, 2018 | -10.30M |
March 31, 2018 | -7.483M |
December 31, 2017 | -9.254M |
September 30, 2017 | -3.827M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-41.13M
Minimum
Jun 2022
33.41M
Maximum
Mar 2021
-18.77M
Average
-23.14M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
The Cooper Companies Inc | 81.20M |
Puma Biotechnology Inc | 12.27M |
Humacyte Inc | -25.11M |
Moderna Inc | -1.175B |
NovaBay Pharmaceuticals Inc | -4.108M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 23.36M |
Total Expenses (Quarterly) | 26.56M |
EPS Diluted (Quarterly) | -0.02 |
Enterprise Value | 673.78M |
Gross Profit Margin (Quarterly) | 91.27% |
Profit Margin (Quarterly) | -4.23% |
Earnings Yield | -2.86% |
Normalized Earnings Yield | -2.857 |